OSUR vs. STAA, CERS, ANIK, UTMD, WST, COO, ALGN, MMSI, ICUI, and HAE
Should you be buying OraSure Technologies stock or one of its competitors? The main competitors of OraSure Technologies include STAAR Surgical (STAA), Cerus (CERS), Anika Therapeutics (ANIK), Utah Medical Products (UTMD), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), and Haemonetics (HAE). These companies are all part of the "health care supplies" industry.
OraSure Technologies vs.
STAAR Surgical (NASDAQ:STAA) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends, community ranking and analyst recommendations.
OraSure Technologies received 264 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 69.13% of users gave OraSure Technologies an outperform vote while only 54.22% of users gave STAAR Surgical an outperform vote.
96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are owned by institutional investors. 1.0% of STAAR Surgical shares are owned by company insiders. Comparatively, 3.4% of OraSure Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
STAAR Surgical presently has a consensus target price of $25.29, indicating a potential upside of 44.82%. OraSure Technologies has a consensus target price of $5.50, indicating a potential upside of 57.59%. Given OraSure Technologies' higher possible upside, analysts plainly believe OraSure Technologies is more favorable than STAAR Surgical.
OraSure Technologies has a net margin of 5.07% compared to STAAR Surgical's net margin of -6.44%. OraSure Technologies' return on equity of 3.55% beat STAAR Surgical's return on equity.
OraSure Technologies has lower revenue, but higher earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.
In the previous week, STAAR Surgical had 12 more articles in the media than OraSure Technologies. MarketBeat recorded 18 mentions for STAAR Surgical and 6 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 1.18 beat STAAR Surgical's score of 1.03 indicating that OraSure Technologies is being referred to more favorably in the news media.
STAAR Surgical has a beta of 0.66, meaning that its stock price is 34% less volatile than the S&P 500. Comparatively, OraSure Technologies has a beta of -0.02, meaning that its stock price is 102% less volatile than the S&P 500.
Summary
OraSure Technologies beats STAAR Surgical on 11 of the 17 factors compared between the two stocks.
Get OraSure Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
OraSure Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:OSUR) was last updated on 3/25/2025 by MarketBeat.com Staff
Buy OSUR Stock Free OSUR Stock Alerts